[1]
|
McCance RA. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years[J]. Q J Med, 1947, 16:33-46. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=HighWire000002578488 |
[2]
|
Chong WH, Molinolo AA, Chen CC, et al. Tumor-induced osteomalacia[J]. Endocr Relat Cancer, 2011, 18:R53-R77. doi: 10.1530/ERC-11-0006 |
[3]
|
Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia:an important cause of adult-onset hypophosphatemic osteomalacia in China:Report of 39 cases and review of the literature[J]. J Bone Miner Res, 2012, 27:1967-1975. doi: 10.1002/jbmr.1642 |
[4]
|
Ogose A, Hotta T, Emura I, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia[J]. Skeletal Radiol, 2001, 30:99-103. doi: 10.1007/s002560000306 |
[5]
|
Uramoto N, Furukawa M, Yoshizaki T. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue[J]. Auris Nasus Larynx, 2009, 36:104-105. doi: 10.1016/j.anl.2008.01.003 |
[6]
|
Prader A, Illig R, Uehlinger E, et al. Rickets following bone tumor[J]. Helv Paediatr Acta, 1959, 14:554-565. http://europepmc.org/abstract/MED/14434619 |
[7]
|
Meyer RA Jr, Meyer MH, Gray RW. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice[J]. J Bone Miner Res, 1989, 4:493-500. doi: 10.1002/jbmr.5650040407/abstract |
[8]
|
Nesbitt T, Coffman TM, Griffiths R, et al. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect[J]. J Clin Invest, 1992, 89:1453-1459. doi: 10.1172/JCI115735 |
[9]
|
Miyauchi A, Fukase M, Tsutsumi M, et al. Hemangiopericytoma-induced osteomalacia:tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity[J]. J Clin Endocrinol Metab, 1988, 67:46-53. doi: 10.1210/jcem-67-1-46 |
[10]
|
Econs MJ, Drezner MK. Tumor-induced osteomalacia-unveiling a new hormone[J]. N Engl J Med, 1994, 330:1679-1681. doi: 10.1056/NEJM199406093302310 |
[11]
|
ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23[J]. Nat Genet, 2000, 26:345-348. doi: 10.1038/81664 |
[12]
|
Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity:an analysis of 32 cases and a comprehensive review of the literature[J]. Am J Surg Pathol, 2004, 28:1-30. doi: 10.1097/00000478-200401000-00001 |
[13]
|
Weidner N. Review and update:oncogenic osteomalacia-rickets[J]. Ultrastruct Pathol, 1991, 15:317-333. doi: 10.3109/01913129109016242 |
[14]
|
张化冰, 潘慧, 李方, 等.奥曲肽显像诊断肿瘤性骨软化一例[J].中华医学杂志, 2005, 85:2375-2376. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx200533020 |
[15]
|
Agrawal K, Bhadada S, Mittal BR, et al. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia[J]. Clin Nucl Med, 2015, 40:e6-e10. doi: 10.1097/RLU.0000000000000460 |
[16]
|
Breer S, Brunkhorst T, Beil FT, et al. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111 In-octreotide SPECT/CT[J]. Bone, 2014, 64:222-227. doi: 10.1016/j.bone.2014.04.016 |
[17]
|
Morimoto T, Takenaka S, Hashimoto N, et al. Malignant phosphaturic mesenchymal tumor of the pelvis:A report of two cases[J]. Oncol Lett, 2014, 8:67-71. doi: 10.3892/ol.2014.2081 |